REVILDA-D 10/100 SR

Combined for Better Protection

Tight Glycemic Control Better QOL

     COMPOSITION

Vildagliptin 100mg + Dapagliflozin 10mg

     INDICATION

  • Type 2 diabetes
  • Hyperglycemia

REVILDA-D 10/100 SR

Dapagliflozin

  •  Increases urinary glucose excretion and reduces blood glucose level
  • Dapagliflozin is highly potent and reversible SGLT2 I and it is > 1400 times more selective for SGLT2 than SGLT1
  •  It effectively controls blood sugar, decreases body weight, and decreases blood pressure
  •  Its cardioprotective and renoprotective properties make it the therapy of choice

Vildagliptin

  • Orally active DPP-41 prevents the inactivation of glucagon-like peptide-1 and improves islet function
  • Rapidly absorbed after oral consumption and efficiently lowers HbA 1C in subjects with type 2 diabetes.
  •  Reduces the amount of glucose produced by the liver by raising insulin levels and decreasing the level of glucagon